Thomas E Lane Selected Research

Proteins (Proteins, Gene)

11/2020	Microglia influence host defense, disease, and repair following murine coronavirus infection of the central nervous system.
1/2019	Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis.
6/2014	Two-photon imaging of remyelination of spinal cord axons by engrafted neural precursor cells in a viral model of multiple sclerosis.
9/2011	Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity.
9/2006	Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas E Lane Research Topics

Disease

47	Infections 01/2022 - 01/2002
32	Demyelinating Diseases (Demyelinating Disease) 11/2020 - 04/2002
18	Virus Diseases (Viral Diseases) 07/2019 - 04/2003
13	Neuroinflammatory Diseases 01/2020 - 02/2006
12	Inflammation (Inflammations) 01/2022 - 04/2003
12	Multiple Sclerosis 01/2019 - 04/2004
5	Coronavirus Infections 01/2022 - 08/2003
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 02/2004
5	Persistent Infection 07/2019 - 01/2006
4	Central Nervous System Infections (Central Nervous System Infection) 01/2022 - 06/2008
3	Chronic Disease (Chronic Diseases) 01/2019 - 01/2006
3	Encephalomyelitis (Myeloencephalitis) 08/2014 - 11/2009
3	Central Nervous System Diseases (CNS Diseases) 01/2014 - 02/2002
3	Acute Disease 01/2013 - 01/2006
3	Herpetic Keratitis 03/2006 - 09/2003
2	Malaria 01/2020 - 01/2013
2	Paralysis (Palsy) 01/2019 - 06/2004
2	Encephalitis (Encephalitis, Rasmussen) 12/2008 - 03/2008
2	Hepatitis 12/2008 - 07/2007
2	Autoimmune Diseases (Autoimmune Disease) 06/2008 - 04/2008
2	Liver Diseases (Liver Disease) 03/2008 - 07/2007
1	COVID-19 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Neoplasms (Cancer) 10/2018
1	Lung Neoplasms (Lung Cancer) 10/2018
1	Disease Progression 01/2016
1	Infarction (Infarctions) 10/2015
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2015
1	Spinal Cord Injuries (Spinal Cord Injury) 09/2013
1	Alzheimer Disease (Alzheimer's Disease) 09/2013
1	Nervous System Diseases (Neurological Disorders) 09/2013
1	Crush Injuries 06/2012
1	Cysts 01/2012
1	Necrosis 09/2011

Drug/Important Bio-Agent (IBA)

23	ChemokinesIBA 01/2022 - 01/2002
15	LigandsIBA 01/2013 - 04/2003
14	CytokinesIBA 01/2022 - 03/2006
10	CXC ChemokinesIBA 06/2010 - 01/2004
7	CC ChemokinesIBA 06/2006 - 04/2003
6	Chemokine ReceptorsIBA 01/2022 - 01/2003
5	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2003
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 09/2006
5	AntigensIBA 07/2019 - 01/2004
5	Chemotactic FactorsIBA 01/2013 - 04/2002
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2010
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022 - 11/2004
3	NK Cell Lectin-Like Receptor Subfamily KIBA 10/2014 - 03/2008
3	Viral AntigensIBA 01/2010 - 09/2003
3	CXCR3 ReceptorsIBA 09/2009 - 03/2006
3	Chemokine CXCL10IBA 08/2008 - 09/2003
3	CCR5 Receptors (CCR5 Receptor)IBA 03/2006 - 08/2003
2	Eukaryotic Initiation Factor-2 (EIF 2)IBA 01/2022 - 11/2021
2	K-18 conjugate (K18)IBA 01/2022 - 11/2021
2	Chemokine CXCL9IBA 01/2022 - 11/2021
2	Messenger RNA (mRNA)IBA 11/2020 - 02/2004
2	Apolipoproteins E (ApoE)IBA 11/2020 - 10/2015
2	Transcription Factors (Transcription Factor)IBA 07/2019 - 10/2018
2	Chemokine CXCL1IBA 01/2018 - 02/2016
2	Fingolimod Hydrochloride (FTY720)FDA Link 10/2015 - 08/2014
2	Interleukin-6 (Interleukin 6)IBA 09/2014 - 01/2004
2	Pharmaceutical PreparationsIBA 08/2014 - 07/2010
2	LipopolysaccharidesIBA 11/2012 - 06/2011
2	Chemokine CCL5IBA 07/2010 - 05/2005
2	CuprizoneIBA 07/2010 - 03/2010
2	Interferon-gamma (Interferon, gamma)IBA 03/2008 - 01/2006
2	CCR2 ReceptorsIBA 06/2006 - 11/2004
1	ApolipoproteinsIBA 11/2020
1	OsteopontinIBA 11/2020
1	Macrophage Colony-Stimulating FactorIBA 11/2020
1	PLX5622IBA 11/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Interleukin-2 (IL2)IBA 07/2019
1	AutoantigensIBA 07/2019
1	Tamoxifen FDA LinkGeneric 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	SOXB1 Transcription FactorsIBA 10/2018
1	Polystyrenes (Polystyrene)IBA 01/2018
1	Capsules (Microcapsules)IBA 01/2018
1	Carcinoembryonic AntigenIBA 11/2017
1	Cell Adhesion MoleculesIBA 11/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Glial Fibrillary Acidic ProteinIBA 02/2016
1	Tetracycline (Achromycin)FDA LinkGeneric 02/2016
1	CholesterolIBA 10/2015
1	Sphingosine-1-Phosphate ReceptorsIBA 10/2015
1	Green Fluorescent ProteinsIBA 06/2014
1	Interleukin-27 (Interleukin 27)IBA 01/2013
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 03/2012
1	MetalsIBA 03/2012
1	ChitinasesIBA 01/2012
1	plerixafor FDA Link 12/2011
1	Fas-Associated Death Domain Protein (Fas-Associating Protein with Death Domain)IBA 09/2011
1	Death Domain ReceptorsIBA 09/2011
1	CaspasesIBA 09/2011
1	Glycogen Synthase (Synthase I)IBA 06/2011

Therapy/Procedure

11	Transplantation 01/2020 - 06/2004
5	Therapeutics 01/2019 - 07/2010
2	Cell Transplantation 01/2019 - 01/2016
2	Laminectomy 06/2012 - 11/2010
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022